Newron
Italy · $39.7M raised
- Employees
- 51–200
- Business Model
- B2B
- Website
- newron.com
- Total Funding
- $39.7M
- Last Round
- $39.7M Corporate RoundFeb 2026
- Rounds
- 3
About
Newron Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for patients with CNS diseases and pain. The company approved product Xadago (safinamide) is a Parkinson disease treatment approved in over 20 markets worldwide.
Summary
Newron is a Biotech company based in Italy. It has raised $39.7M in total across 3 rounds, most recently a $39.7M Corporate Round round in Feb 2026. Investors include Omega Funds, 3i and TVM Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...